Prince Akwasi Mensah

Array ( [id] => 1405131 [patent_doc_number] => 06534543 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-03-18 [patent_title] => 'Oxa acids and related compounds for treating skin conditions' [patent_app_type] => B2 [patent_app_number] => 09/957923 [patent_app_country] => US [patent_app_date] => 2001-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6917 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 104 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/534/06534543.pdf [firstpage_image] =>[orig_patent_app_number] => 09957923 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7629687 [patent_doc_number] => 06818669 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-11-16 [patent_title] => 'Increasing cerebral bioavailability of drugs' [patent_app_type] => B2 [patent_app_number] => 09/955485 [patent_app_country] => US [patent_app_date] => 2001-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 11719 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/818/06818669.pdf [firstpage_image] =>[orig_patent_app_number] => 09955485 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6721409 [patent_doc_number] => 20030055099 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-20 [patent_title] => 'Materials and methods for treatment of neurological disorders involving overactivation of glutamatergic ionotropic receptors' [patent_app_type] => new [patent_app_number] => 09/957358 [patent_app_country] => US [patent_app_date] => 2001-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6564 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0055/20030055099.pdf [firstpage_image] =>[orig_patent_app_number] => 09957358 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6262008 [patent_doc_number] => 20020187985 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-12-12 [patent_title] => 'Method and composition for the treatment of lipid and glucose metabolism disorders' [patent_app_type] => new [patent_app_number] => 09/950167 [patent_app_country] => US [patent_app_date] => 2001-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 10062 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0187/20020187985.pdf [firstpage_image] =>[orig_patent_app_number] => 09950167 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5923284 [patent_doc_number] => 20020115661 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-22 [patent_title] => 'Method for treating chronic obstructive pulmonary disease' [patent_app_type] => new [patent_app_number] => 09/949204 [patent_app_country] => US [patent_app_date] => 2001-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5509 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0115/20020115661.pdf [firstpage_image] =>[orig_patent_app_number] => 09949204 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1180589 [patent_doc_number] => 06740672 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-05-25 [patent_title] => 'Use of 5HT3-receptor antagonists for the treatment of chronic fatigue syndrome' [patent_app_type] => B1 [patent_app_number] => 09/868972 [patent_app_country] => US [patent_app_date] => 2001-09-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1854 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/740/06740672.pdf [firstpage_image] =>[orig_patent_app_number] => 09868972 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1489370 [patent_doc_number] => 06416808 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-07-09 [patent_title] => 'Method of obtaining a hydroxytyrosol-rich composition from vegetation water' [patent_app_type] => B1 [patent_app_number] => 09/944744 [patent_app_country] => US [patent_app_date] => 2001-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 4646 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/416/06416808.pdf [firstpage_image] =>[orig_patent_app_number] => 09944744 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1417121 [patent_doc_number] => 06521665 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-02-18 [patent_title] => 'Method of treating insulin resistance' [patent_app_type] => B1 [patent_app_number] => 09/914499 [patent_app_country] => US [patent_app_date] => 2001-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3031 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/521/06521665.pdf [firstpage_image] =>[orig_patent_app_number] => 09914499 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1419886 [patent_doc_number] => 06514960 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-02-04 [patent_title] => 'Use of bismuth subgallate in inhibition of production of nitric oxide synthase' [patent_app_type] => B1 [patent_app_number] => 09/940405 [patent_app_country] => US [patent_app_date] => 2001-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 2425 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/514/06514960.pdf [firstpage_image] =>[orig_patent_app_number] => 09940405 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6343741 [patent_doc_number] => 20020035057 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-03-21 [patent_title] => 'Treatment of movement disorders by administration of 5-hydroxytryptamine receptor/alpha2 adrenergic receptor antagonist compositions' [patent_app_type] => new [patent_app_number] => 09/940309 [patent_app_country] => US [patent_app_date] => 2001-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5957 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0035/20020035057.pdf [firstpage_image] =>[orig_patent_app_number] => 09940309 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1401892 [patent_doc_number] => 06538030 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-03-25 [patent_title] => 'Treating radiation fibrosis' [patent_app_type] => B2 [patent_app_number] => 09/938926 [patent_app_country] => US [patent_app_date] => 2001-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5449 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/538/06538030.pdf [firstpage_image] =>[orig_patent_app_number] => 09938926 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1360832 [patent_doc_number] => 06573300 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-06-03 [patent_title] => 'Hydroxyurea treatment for spinal muscular atrophy' [patent_app_type] => B2 [patent_app_number] => 09/938934 [patent_app_country] => US [patent_app_date] => 2001-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 10855 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/573/06573300.pdf [firstpage_image] =>[orig_patent_app_number] => 09938934 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6096874 [patent_doc_number] => 20020052361 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-05-02 [patent_title] => 'Pharmaceutical compositions and method for the treatment of hypertension' [patent_app_type] => new [patent_app_number] => 09/930186 [patent_app_country] => US [patent_app_date] => 2001-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4025 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0052/20020052361.pdf [firstpage_image] =>[orig_patent_app_number] => 09930186 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1286460 [patent_doc_number] => 06638976 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-10-28 [patent_title] => 'Method of treating neurodegenerative disorders of the retina and optic nerve head' [patent_app_type] => B2 [patent_app_number] => 09/929704 [patent_app_country] => US [patent_app_date] => 2001-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1524 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 195 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/638/06638976.pdf [firstpage_image] =>[orig_patent_app_number] => 09929704 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1478785 [patent_doc_number] => 06451828 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-09-17 [patent_title] => 'Selective inhibition of glutaminase by bis-thiadiazoles' [patent_app_type] => B1 [patent_app_number] => 09/927207 [patent_app_country] => US [patent_app_date] => 2001-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 9 [patent_no_of_words] => 6696 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 128 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/451/06451828.pdf [firstpage_image] =>[orig_patent_app_number] => 09927207 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6128599 [patent_doc_number] => 20020076470 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-06-20 [patent_title] => 'Composition and method' [patent_app_type] => new [patent_app_number] => 09/922660 [patent_app_country] => US [patent_app_date] => 2001-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1965 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0076/20020076470.pdf [firstpage_image] =>[orig_patent_app_number] => 09922660 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6225517 [patent_doc_number] => 20020004528 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-01-10 [patent_title] => 'Method for the treatment of insomnia' [patent_app_type] => new [patent_app_number] => 09/921682 [patent_app_country] => US [patent_app_date] => 2001-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1810 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20020004528.pdf [firstpage_image] =>[orig_patent_app_number] => 09921682 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7001052 [patent_doc_number] => 20010053777 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-12-20 [patent_title] => 'Drug treatment for restless leg syndrome' [patent_app_type] => new [patent_app_number] => 09/919731 [patent_app_country] => US [patent_app_date] => 2001-08-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3417 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20010053777.pdf [firstpage_image] =>[orig_patent_app_number] => 09919731 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6640065 [patent_doc_number] => 20030212082 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-13 [patent_title] => 'Use of selective adenosine a1 receptor agonists, antagonists and allosteric enhancers to manipulate angiogenesis' [patent_app_type] => new [patent_app_number] => 10/343587 [patent_app_country] => US [patent_app_date] => 2003-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 6208 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0212/20030212082.pdf [firstpage_image] =>[orig_patent_app_number] => 10343587 [rel_patent_id] =>[rel_patent_doc_number] =>)